Netherlands· NL-a1e099904f94
Atosiban Accord 6,75 mg/0,9 ml oplossing voor injectie in een voorgevulde spuit
A atosiban product containing atosibanacetaat, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Atosiban is registered in 14 of 19 countries.
Countries holding a registration under ATC G02CX01 (atosiban), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Atosiban · ATC G02CX01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ATOSIBANACETAAT
- Manufacturer
- Accord Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- G02CX01
- ATC class
- Atosiban
- Defined daily dose
- 165 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id120953
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atosiban in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceATOSIBAN ACCORD 6,75 mg/0,9 ml, solution injectable en seringue préremplieACCORD HEALTHCARE FRANCE
- SpainATOSIBAN ACCORD 37,5 MG/5 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- United KingdomAtosiban 37.5mg/5ml concentrate for solution for infusion vialsStragen UK Ltd
- FinlandAtosiban AccordAccord Healthcare B.V.
- BelgiumAtosiban Altan 37.5 mg/5 mlAltan Pharma
- PolandAtosiban AccordAccord Healthcare Polska Sp. z o.o.
- SwedenAtosiban Accord 37,5 mg/5 ml Koncentrat till infusionsvätska, lösningAccord Healthcare B.V.
- CzechiaATOSIBAN AVMCAV Medical CZ s.r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Atosiban Altan, Atosiban Ever Pharma
- Belgium · Atosiban Ever Pharma
- Bulgaria · Атозибан Ever Pharma
- Czechia · Atosiban Avmc, Atosiban Ever Pharma
- Germany · Atosiban Ever Pharma, Atosiban Ibisqus
- Denmark · Atosiban Ever Pharma
- Spain · Atosiban Altan Pharmaceuticals, S.A., Atosiban Ever Pharma
- Finland · Atosiban Ever Pharma
- France · Atosiban Altan, Atosiban Altan Pharmaceuticals, S.A.
- United Kingdom (Northern Ireland) · Atosiban Ibigen
- Greece · Atosiban Ever Pharma
- Croatia · Atosiban Ever Pharma, Atosiban Makpharm
- Iceland · Atosiban Sun, Tractocile
- Italy · Atosiban Ever Pharma, Atosiban Ibisqus
- Liechtenstein · Tractocile
- Luxembourg · Atosiban Ever Pharma
- Latvia · Atosiban Pharmidea
- Norway · Atosiban Ever Pharma, Atosiban Sun
- Poland · Atosiban Ever Pharma
- Portugal · Atosiban Ever Pharma, Atosibano Altan
- Sweden · Atosiban Accord, Atosiban Ever Pharma
- Slovenia · Atoziban Ever Pharma
- Slovakia · Atosiban Ardez
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f00f133d-b093-406a-b8a8-654f18ac1c93 GET /v1/drugs/f00f133d-b093-406a-b8a8-654f18ac1c93?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h120953_smpc.pdf",
"strength": null,
"atc_label": "Atosiban",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg120953",
"excipients": [
"MANNITOL (D-) (E 421)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"ATOSIBANACETAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h120953.pdf",
"authorised_at": "2018/08/07",
"procedure_number": "NL/H/4551/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "120953",
"additional_monitoring": "N"
}See everything about atosiban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.